Company Filing History:
Years Active: 2022-2025
Title: Ilka Mathar: Innovator in Biomedicine
Introduction
Ilka Mathar is a prominent inventor based in Düsseldorf, Germany. She has made significant contributions to the field of biomedicine, holding a total of 3 patents. Her work focuses on innovative treatments for various diseases, showcasing her expertise and dedication to advancing medical science.
Latest Patents
One of her latest patents is titled "Atrial natriuretic peptide engrafted antibodies." This invention relates to an antibody or a fragment that includes at least one heterologous amino acid sequence within its CDR regions. The invention aims to provide a method for treatment using this antibody, along with a composition that includes it, and a process for producing such antibodies.
Another notable patent is for "Substituted pyrazolo piperidine carboxylic acids." This invention encompasses substituted pyrazolo piperidine carboxylic acids and their salts, which are used in preparing medicaments for treating cardiovascular diseases, hypertension, and various other medical conditions.
Career Highlights
Ilka Mathar is currently employed at Bayer Aktiengesellschaft, a leading global company in the pharmaceutical and life sciences sector. Her role at Bayer allows her to work on cutting-edge research and development projects that aim to improve patient outcomes and address critical health challenges.
Collaborations
Throughout her career, Ilka has collaborated with notable colleagues, including Lucas Hudson Hofmeister and Peter Sandner. These collaborations have further enriched her research and contributed to the success of her innovative projects.
Conclusion
Ilka Mathar's contributions to biomedicine through her patents and work at Bayer Aktiengesellschaft highlight her as a key figure in the field. Her innovative approaches to treatment continue to pave the way for advancements in healthcare.